# Drug Interaction Study With Proton Pump Inhibitor

> **NCT00357240** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 56 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Atazanavir
- **DRUG:** Atazanavir/Ritonavir
- **DRUG:** Atazanavir/Ritonavir+Omeprazole
- **DRUG:** Atazanavir/Ritonavir+Omeprazole
- **DRUG:** Atazanavir
- **DRUG:** Atazanavir/Ritonavir
- **DRUG:** Atazanavir/Ritonavir+Omeprazole
- **DRUG:** Atazanavir/Ritonavir+Omeprazole

## Key facts

- **NCT ID:** NCT00357240
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 56 (—)
- **Last updated:** 2011-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00357240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00357240, "Drug Interaction Study With Proton Pump Inhibitor". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00357240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*